Recurrent genetic defects on chromosome 5q in myeloid neoplasms
Hosono, Naoko, Makishima, Hideki, Mahfouz, Reda, Przychodzen, Bartlomiej, Yoshida, Kenichi, Jerez, Andres, LaFramboise, Thomas, Polprasert, Chantana, Clemente, Michael J, Shiraishi, Yuichi, Chiba, Kenichi, Tanaka, Hiroko, Miyano, Satoru, Sanada, Masashi, Cui, Edward, Verma, Amit K, McDevitt, Michael A, List, Alan F, Saunthararajah, Yogen, Sekeres, Mikkael A, Boultwood, Jacqueline, Ogawa, Seishi, Maciejewski, Jaroslaw P
Published in Oncotarget (24.01.2017)
Published in Oncotarget (24.01.2017)
Get full text
Journal Article
Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia
Pal, Rekha, Monaghan, Sara A., Hassett, Andrea Cortese, Mapara, Markus Y., Schafer, Peter, Roodman, G. David, Ragni, Margaret V., Moscinski, Lynn, List, Alan, Lentzsch, Suzanne
Published in Blood (21.01.2010)
Published in Blood (21.01.2010)
Get full text
Journal Article
Valuation of transfusion-free living in MDS: results of health utility interviews with patients
Szende, Agota, Schaefer, Caroline, Goss, Thomas F, Heptinstall, Kathy, Knight, Robert, Lübbert, Michael, Deschler, Barbara, Fenaux, Pierre, Mufti, Ghulam J, Killick, Sally, List, Alan F
Published in Health and quality of life outcomes (08.09.2009)
Published in Health and quality of life outcomes (08.09.2009)
Get full text
Journal Article
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia
Pogosova-Agadjanyan, Era L, Kopecky, Kenneth J, Ostronoff, Fabiana, Appelbaum, Frederick R, Godwin, John, Lee, Hana, List, Alan F, May, Jennifer J, Oehler, Vivian G, Petersdorf, Steve, Pogosov, Galina L, Radich, Jerald P, Willman, Cheryl L, Meshinchi, Soheil, Stirewalt, Derek L
Published in PloS one (14.08.2013)
Published in PloS one (14.08.2013)
Get full text
Journal Article
Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?
Zeidan, Amer M., Sekeres, Mikkael A., Wang, Xiao‐Feng, Al Ali, Najla, Garcia‐Manero, Guillermo, Steensma, David P., Roboz, Gail, Barnard, John, Padron, Eric, DeZern, Amy, Maciejewski, Jaroslaw P., List, Alan F., Komrokji, Rami S.
Published in American journal of hematology (01.11.2015)
Published in American journal of hematology (01.11.2015)
Get full text
Journal Article
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors
Navas, Tony A., Mohindru, Mani, Estes, Myka, Ma, Jing Ying, Sokol, Lubomir, Pahanish, Perry, Parmar, Simrit, Haghnazari, Edwin, Zhou, Li, Collins, Robert, Kerr, Irene, Nguyen, Aaron N., Xu, Yin, Platanias, Leonidas C., List, Alan A., Higgins, Linda S., Verma, Amit
Published in Blood (15.12.2006)
Published in Blood (15.12.2006)
Get full text
Journal Article
Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
Bellamy, William T., Richter, Lynne, Sirjani, Davuud, Roxas, Concepcion, Glinsmann-Gibson, Betty, Frutiger, Yvette, Grogan, Thomas M., List, Alan F.
Published in Blood (01.03.2001)
Published in Blood (01.03.2001)
Get full text
Journal Article
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome
Raza, Azra, Galili, Naomi, Smith, Scott E., Godwin, John, Boccia, Ralph V., Myint, Han, Mahadevan, Daruka, Mulford, Deborah, Rarick, Mark, Brown, Gail L., Schaar, Dale, Faderl, Stefan, Komrokji, Rami S., List, Alan F., Sekeres, Mikkael
Published in Cancer (15.04.2012)
Published in Cancer (15.04.2012)
Get full text
Journal Article
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities
Sallman, David A., Barnard, John, Al Ali, Najla H., Garcia-Manero, Guillermo, Sekeres, Mikkael A., DeZern, Amy, Steensma, David P., Roboz, Gail, Jabbour, Elias, Maciejewski, Jaroslaw P., Pierce, Sherry, Padron, Eric, Lancet, Jeffrey E., Kantarjian, Hagop, List, Alan F., Komrokji, Rami S.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Get full text
Journal Article
Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning
Sallman, David A., Bejar, Rafael, Montalban-Bravo, Guillermo, Kurtin, Sandra E., List, Alan F., Garcia-Manero, Guillermo, Nimer, Stephen D., O'Connell, Casey L., Schaar, Dale, Butchko, Janice, Iraca, Tracey, Searle, Stephanie
Published in Leukemia research reports (01.01.2022)
Published in Leukemia research reports (01.01.2022)
Get full text
Journal Article
Evidence for Selective Benefit of Sequential Treatment with Hypomethylating agents in Patients with Myelodysplastic Syndrome (MDS)
Apuri, Susmitha, Al Ali, Najla, Padron, Eric, Lancet, Jeffrey E, List, Alan F, Komrokji, Rami S
Published in Clinical lymphoma, myeloma and leukemia (01.04.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.04.2017)
Get full text
Journal Article
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Pogosova-Agadjanyan, Era L, Moseley, Anna, Othus, Megan, Appelbaum, Frederick R, Chauncey, Thomas R, Chen, I-Ming L, Erba, Harry P, Godwin, John E, Jenkins, Isaac C, Fang, Min, Huynh, Mike, Kopecky, Kenneth J, List, Alan F, Naru, Jasmine, Radich, Jerald P, Stevens, Emily, Willborg, Brooke E, Willman, Cheryl L, Wood, Brent L, Zhang, Qing, Meshinchi, Soheil, Stirewalt, Derek L
Published in Biomarker research (12.08.2020)
Published in Biomarker research (12.08.2020)
Get full text
Journal Article
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents
Nazha, Aziz, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Barnard, John, Al Ali, Najla H, Roboz, Gail J, Steensma, David P, DeZern, Amy E, Zimmerman, Cassie, Jabbour, Elias J, Zell, Katrina, List, Alan F, Kantarjian, Hagop M, Maciejewski, Jaroslaw P, Komrokji, Rami S
Published in Leukemia research (01.02.2016)
Published in Leukemia research (01.02.2016)
Get full text
Journal Article
ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia
Padron, Eric, Yoder, Sean, Kunigal, Sateesh, Mesa, Tania, Teer, Jamie K., Al Ali, Najla, Sekeres, Mikkael A., Painter, Jeffrey S., Zhang, Ling, Lancet, Jeffrey, Maciejewski, Jaroslaw P., Epling-Burnette, Pearlie K., Sotomayor, Eduardo, Komrokji, Rami S., List, Alan F.
Published in Blood (05.06.2014)
Published in Blood (05.06.2014)
Get full text
Journal Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy: Analysis from a large, single institution experience
Griffin, Patrick T., Komrokji, Rami S., Sweet, Kendra, Al Ali, Najla H., Padron, Eric, Kubal, Timothy E., List, Alan F., Lancet, Jeffrey E.
Published in American journal of hematology (01.03.2017)
Published in American journal of hematology (01.03.2017)
Get full text
Journal Article